ロード中...
Targeting the Hepatocyte Growth Factor–cMET Axis in Cancer Therapy
The hepatocyte growth factor (HGF) and its receptor, the transmembrane tyrosine kinase cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic changes that stimulate tissue repair and regeneration in normal cells but can be co-opted during tumor growth. MET overexpr...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Clinical Oncology
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3434988/ https://ncbi.nlm.nih.gov/pubmed/22869872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.40.3774 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|